2006-2007 Stem Cell Events and Activities

Events

Social Science Research on Stem Cell Science: A View From the UK
Steven Wainwright, King's College London, University of London
Date: September 26, 2006

Ethical Worlds of Stem Cell Medicine Conference
Dates: September 28th and 29th, 2006 at UCB and UCSF

2006 – 2007 Coleman Fung Distinguished Lecture on Science in a Globalizing World
Experiments without Borders: Biology in the Labs of Life
Sheila Jasanoff, Pforzheimer Professor of Science and Technology Studies, Harvard University
Date: October 6th, 2006

Toward Fair Cures: Integrating the Benefits of Diversity in California’s Stem Cell Research Program
Date: October 14th, 2006

From the Cyborg Embryo to Transbiology: the IVF - Stem Cell Interface in the UK
Sarah Franklin, Professor of Social Studies of Biomedicine and Convenor of the MSc in Biomedicine, Bioscience and Society, London School of Economics
Date: November 15th, 2006

Translation and Transplantation: Stem Cells in History
Jane Maienschein, Arizona State University
Date: December 4th, 2006

Legislating Biotechnology:
Issues after a decade of stem cells and genetic testing
Paul Billings, Senior Geneticist in the Center for Molecular Biology and Pathology, Laboratory Corporation of America
Date: February 6th, 2007

“What’s Left of Life” Conference
Date: February 16th and 17th, 2007

BIO[X]: New Iterations of Lively Bodies
SCIENCE STUDIES GRADUATE STUDENT CONFERENCE
Date: February 23rd, 2007

Neuropolitics: To Define True Madness
Nikolas Rose, Professor of Sociology and Director of the BIOS Research Centre for the study of Bioscience, Biomedicine, Biotechnology and Society, London School of Economics and Political Science
Date: February 28th, 2007

Stem Cell Research and the Politics of Religion
Nancy Duff, Stephen Colwell Associate Professor of Christian Ethics, Princeton Theological Seminary
Date: March 13th, 2007

Diversity in California’s Stem Cell Initiative
Josef Tayag, Program Manager in Health, Greenlining Institute
Date: March 15th, 2007

California Institute for Regenerative Medicine: Ethics and Accountability
Geoff Lomax, CIRM Senior Officer for Medical and Ethical Standards
Date: March 22nd, 2007

CIRM IP Policies in the Context of National and International IP
Kenneth Taymor, Attorney, MBV LAW LLP in San Francisco
Date: April 5th, 2007

A Conversation on the Teaching of Race, Genetics and Science
Facilitator: Richard Candida-Smith, Department of History
Presenter: Troy Duster, Department of Sociology
Presenter: Jasper Rine, Department of Molecular and Cell Biology
Presenter: Charis Thompson, Rhetoric and Gender & Women''s Studies
Date: April 18th, 2007

Biobanking
David Winickoff, Assistant Professor, ESPM
Date: April 26th, 2007

At the Border: Issues of Trade and Commerce in Stem Cell Research and Medicine
Christopher Thomas Scott, Director, Stem Cells and Society, Stanford University
Date: May 3rd, 2007

Projects

Regeneration: the Life Sciences and the Humanities Strategic Working Group
The Mellon Strategic Group is engaged in topics at the intersection of the Life Sciences and the Humanities, demonstrating the depth of humanities and social science faculty members who are not only interested, but are uniquely qualified to work together in this area based on their expertise in the subject matter. The group is looking at historical, anthropological, and humanistic approaches to such arenas as bio-security, biomedicine, AIDS, the pharmaceutical and chemical industries, synthetic biology, bio-energy, and reproductive technologies. Charis Thompson, one of the co-convenors of the project, reports that “beyond these focal points, some of the issues upon which the group is focusing include new and old intersections between race and genetics; the life sciences in film and literature; feminist and philosophical discourses on life and life politics; the role of bioethics as a form of research governance in the U.S. and transnationally; intellectual property and other languages and mechanisms of ownership, access, and circulation; changing definitions of sciences’ “publics” in new and shifting relationships among the military, the academy, and industry; and global aspects of science, technology, and medicine in both historical and contemporary frames.”